Nu Skin director sells shares after stock grant

Nu Skin Enterprises director James M. Winett reported both an equity grant and a sale of Class A Common Stock.

Rhea-AI Filing Summary

Nu Skin Enterprises director James M. Winett reported both an equity grant and a sale of Class A Common Stock. On June 1, 2026, he acquired 26,643 shares as a grant at $0.00 per share. On June 2, 2026, he executed an open-market sale of 7,203 shares at $5.62 per share pursuant to a Rule 10b5-1(c) trading plan adopted on November 11, 2025. After these transactions, he directly holds 37,448 shares of Nu Skin’s Class A Common Stock, indicating he retained a substantial position following the sale.

Insider Trade Summary 10b5-1

Net Seller: 7,203 shares

Net Sell 2 txns

Insider Winett James M

Role Director

Sold 7,203 shs ($40K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	7,203	$5.62	$40K
Grant/Award	Class A Common Stock	26,643	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 37,448 shares (Direct)

Footnotes (1)

1. F1. The reported transaction occurred pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 11, 2025.

Key Figures

Shares sold: 7,203 shares Sale price: $5.62 per share Shares granted: 26,643 shares +1 more

4 metrics

Shares sold 7,203 shares Open-market sale of Class A Common Stock on June 2, 2026 at $5.62

Sale price $5.62 per share Price for 7,203 Nu Skin Class A shares sold on June 2, 2026

Shares granted 26,643 shares Grant/award acquisition of Class A Common Stock on June 1, 2026

Post-transaction holdings 37,448 shares Direct Class A Common Stock held after reported transactions

Key Terms

Rule 10b5-1(c), open-market sale, grant/award acquisition, Class A Common Stock

4 terms

Rule 10b5-1(c) regulatory

"pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 11, 2025"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

open-market sale financial

"transaction_action: open-market sale of Class A Common Stock at $5.62 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

grant/award acquisition financial

"transaction_action: grant/award acquisition of 26,643 shares at $0.00 per share"

Class A Common Stock financial

"security_title: Class A Common Stock for both the grant and sale transactions"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Nu Skin (NUS) director James M. Winett report?

James M. Winett reported receiving a large stock grant and then selling a smaller portion. He acquired 26,643 Nu Skin Class A shares on June 1, 2026, and sold 7,203 shares on June 2, 2026, while retaining 37,448 shares afterward.

How many Nu Skin (NUS) shares did James M. Winett sell and at what price?

He sold 7,203 shares of Nu Skin Class A Common Stock at an average price of $5.62 per share. This open-market sale was disclosed as part of a Form 4 filing and occurred one day after receiving a 26,643-share grant.

What stock grant did Nu Skin (NUS) director James M. Winett receive?

He received a grant of 26,643 shares of Nu Skin Class A Common Stock on June 1, 2026, at a reported price of $0.00 per share. This reflects a compensation-related award rather than an open-market purchase, increasing his direct holdings before the subsequent sale.

How many Nu Skin (NUS) shares does James M. Winett hold after these transactions?

Following the reported grant and subsequent sale, James M. Winett directly holds 37,448 shares of Nu Skin Class A Common Stock. This figure reflects his remaining position after selling 7,203 shares, indicating that he kept a significant stake in the company.

Were James M. Winett’s Nu Skin (NUS) share sales made under a Rule 10b5-1 plan?

Yes. The filing states the reported sale occurred under a trading plan intended to comply with Rule 10b5-1(c), adopted on November 11, 2025. Such pre-arranged plans schedule trades in advance, indicating the timing was set before the transaction date.

Is James M. Winett’s Nu Skin (NUS) transaction mainly a sale or an acquisition?

The Form 4 shows both acquisition and sale activity, but the acquisition is larger. He received 26,643 shares as a grant and sold 7,203 shares, resulting in a net increase in his direct holdings to 37,448 Nu Skin Class A shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 05:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Winett James M

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UTAH 84061

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/01/2026		A		26,643	A	$0.00	44,651	D
Class A Common Stock	06/02/2026		S		7,203(1)	D	$5.62	37,448	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction occurred pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 11, 2025.

	/s/ Gregory Belliston as Attorney-in-Fact for James Winett	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)